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Introduction 
Thrombolysis and endovascular interventions have revolutionised stroke treatment, but many 
patients are excluded from such therapies, and residual disability is common.1 Emerging 
approaches to enhance post-stroke brain repair may have no time constraints and are 
applicable to most stroke patients. Novel interventions to enhance brain repair include 
electromagnetic or robotic techniques, brain-computer interface, and restorative cell-based 
and pharmacological therapies.2-4 A major impediment to translation to patient care, however, 
is the lack of robust in vivo techniques to monitor the effects of such interventions in 
humans.3  
 
Non-invasive imaging of the human brain for multi-parametric in vivo monitoring of post-
stroke recovery presents challenges. The clinical application of certain techniques such as 
positron emission tomography (PET) is frequently restricted by radiation exposure, limited 
resolution, high cost, or difficult access.5-7 Magnetic resonance (MR) imaging (MRI) on the 
other hand is accessible, non-invasive, safe and versatile with high resolution, making this an 
ideal modality for multi-parametric in vivo monitoring of stroke recovery. This review will 
concentrate on MRI markers of stroke recovery in experimental models and, where available, 
in humans (Table 1).  
 
 
Biological substrates of neural repair  
Angiogenesis 
The peri-infarct cortex is a unique neurovascular niche, within which angiogenesis is closely 
and causally linked to neurogenesis through vascular growth factors and chemokines.2 
Together with parenchymal astrocytes, angiogenic vessels facilitate synaptogenesis and 
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axonal sprouting.2 Angiogenesis stimulated by cell-based or pharmacological interventions 
correlates with improved behavioural outcome.2 In rodents, capillary sprouting at the 
ischemic boundary leads to new vessel development between 2 and 28 days.8 Angiogenesis 
has been observed in the ischemic penumbra of humans 3 to 4 days after stroke, and higher 
cerebral blood vessel density has been associated with improved survival.9 Angiogenic 
vessels are permeable during the early stages of development and become less leaky as they 
mature, potentially allowing new vessels to be distinguished by imaging techniques.10  
 
Neurogenesis 
In experimental stroke, focal ischemia increases neurogenesis in distinct parts of the 
ipsilateral subependymal zone (SEZ), and neuroblasts migrate from the SEZ to the ischemic 
boundary regions, where they exhibit phenotypes of mature neurons (Figure1).11-13 It has 
been shown in rat models that migration of immature cells from the SEZ occurs over the first 
2 weeks, but can be sustained for several months.14 Neurogenesis after stroke has been 
associated with functional recovery in mice.15 In humans, post-mortem studies have 
demonstrated active proliferation of astrocytes, neuroblasts, migrating neuroblasts and 
immature neurons in the ipsilateral SEZ at 10 days after stroke.16-18 Cells expressing markers 
of new-born neurons have been detected in the ischemic penumbra of humans, where they 
cluster around blood vessels.16, 19 
 
Axonal remodeling 
It has been shown in rats that neurons in the surviving peri-infarct cortex are induced to 
express a growth-associated genetic profile that enhances axonal sprouting and mediates the 
formation of new connections.20 In experimental stroke, axonal sprouting occurs in a growth-
permissive zone outside the glial scar within the peri-infarct cortex, and also up to several 
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millimetres away from the infarct.21 Significantly increased axonal connections, originating 
from the peri-infarct motor cortex, have been demonstrated during recovery in rodent and 
primate models, correlating well with behavioural outcome.22, 23  
 
 
Imaging of Biological Substrates 
Angiogenesis 
Although direct depiction of microvessels with MR angiography is not feasible due to its 
relatively low spatial resolution, there are many MRI parameters that can be used to monitor 
angiogenesis and vascular remodeling after stroke indirectly (Table 1).24, 25 
 
Hemodynamic parameters affected by angiogenesis, such as cerebral blood volume (CBV) 
and cerebral blood flow (CBF), can be measured with perfusion techniques such as dynamic 
susceptibility contrast-enhanced (DSC-) MRI or arterial spin labelling (ASL).25 DSC-MRI 
calculates cerebral hemodynamic parameters from the time course of signal changes induced 
by the first passage of an intravenously injected paramagnetic contrast agent.26 DSC-MRI has 
demonstrated significantly increased CBV in the recovering ipsilesional cortex of rodent 
stroke models, which correlated well with increased vascular density on histology.27, 28 The 
ASL method applies radiofrequency pulses to alter the magnetisation of water protons in 
arterial blood, thereby generating an endogenous intravascular tracer.29 Using ASL, a 
significantly enhanced CBF has been demonstrated in the perilesional cortex in rat models, 
that correlated with vascular density.28, 30  
 
The low specificity of DSC-MRI or ASL for angiogenesis may be overcome by steady state 
susceptibility contrast-enhanced (SSCE)-MRI, which allows estimation of blood volume, 
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vessel size, and microvessel density.25 The ratio of changes in gradient-echo to spin-echo 
relaxation rate (R2*/R2) induced by a high-molecular weight intravascular contrast agent 
provides an estimate of average vessel size after accounting for echo time, contrast 
concentration, and the main magnetic field.31 The ratio QR2/(R2*)2/3 characterises 
microvascular density (MVD).32 In a rat model of transient cerebral ischemia, SSCE-MRI 
showed decrease in vascular density and increase in vessel size due to strengthened collateral 
circulation in the re-perfused cortex at days 1 and 3, confirmed on histology, followed by an 
increase in vascular density likely attributable to angiogenesis at days 14 and 21.33 
 
Increased permeability of the blood-brain-barrier around newly formed vessels can be 
assessed in humans and animal models with dynamic contrast-enhanced (DCE-) MRI, which 
measures the time-course of contrast-induced changes in the T1 relaxation time constant due 
to contrast agent extravasation into tissue.34 The blood-brain-barrier transfer constant, Ki, can 
be estimated by locally assessing the dynamics of the signal intensity of a time-series of T1-
weighted MR images with tracer kinetic models.35 In a rat stroke model, Ki in the ischemic 
boundary correlated with histologically confirmed angiogenesis after cell-based treatment.27 
The increase of Ki, peaking at 2-3 weeks, co-localized with elevated CBF and CBV at 6 
weeks after cell therapy. In another study, Ki elevation was detected 1-3 weeks after stroke in 
sildenafil treated animals compared with 1-6 weeks in controls, suggesting that therapy 
accelerates angiogenesis and this is measurable with imaging.36  
 
Newly developed vasculature rich in venous blood can be detected with blood oxygenation 
level-dependent (BOLD) MRI.36 This exploits the local magnetic field disturbances induced 
by the relatively high magnetic susceptibility of deoxygenated haemoglobin, which provides 
T2 contrast on spin echo images and a larger T2* contrast on gradient echo images.37 
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Susceptibility weighted imaging (SWI), a variant of T2* weighted MRI that includes phase 
information, can further enhance the contrast of the areas with increased magnetic 
susceptibility.24, 38 In a rat model of stroke, perilesional angiogenesis was successfully 
identified on T2* and SWI maps.36 These techniques also detected an accelerated 
angiogenetic profile with sildenafil, and regions exhibiting T2* shortening spatially matched 
with those with elevated Ki.36 T2* shortening in the ischemic hemisphere spatiotemporally 
corresponded with increased CBF on ASL in rats.30  
 
MRI can be used to measure haemodynamic parameters, microvascular density, blood-brain 
barrier permeability, and deoxygenated haemoglobin, all of which are potential markers of 
angiogenesis and vascular remodeling. However, MRI is not without limitations and MRI 
techniques differ in their availability and suitability for clinical use. MRI measurement 
algorithms are also based on relatively basic biophysical and mathematical models which 
may be inaccurate under complex or altered conditions seen with stroke.25  
 
DSC-MRI is arguably the most widely available perfusion MRI technique in the clinical 
setting, but DSC-MRI methods are not fully quantitative, and thus provide information with 
regard to the relative CBF and CBV.39 BOLD methods are also widely available and easily 
implemented but are again able to provide only a qualitative assessment of 
deoxyhaemoglobin concentration or T2*. ASL methods are arguably more quantitative and in 
recent years have become increasingly available, although most ASL methods do not provide 
a measure of CBV.39 Both DSC-MRI and ASL are sensitive to errors arising from an increase 
in arterial transit time to the peri-infarct tissue, and DSC-MRI perfusion values can also be 
confounded by dispersion of the tracer input function or T1 changes from blood brain barrier 
disruption.39 In addition, while ASL and DSC-MRI offer good sensitivity to perfusion 
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changes during stroke recovery, alterations in CBF and CBV may reflect vasodilation or 
metabolic changes (Figure 2), so these perfusion measures may not offer a high specificity 
for angiogenesis per se. Similarly, an increase in Ki (from DCE-MRI) or a shortening of T2* 
may arise because of other vascular pathology.25 SSCE-MRI measures of microvascular 
density and vessel size arguably offer the greatest specificity for angiogenesis, but currently 
suffer from limited availability, especially within the clinical setting.  
 
Neurogenesis 
There are inherent limitations of resolution and sensitivity that preclude the direct 
visualization of endogenous neurogenesis. The unique metabolic properties of newly 
generated cells, however, can serve as surrogate markers. Magnetic resonance spectroscopy 
(MRS) potentially allows the in vivo measurement of marker compounds associated with 
different cell types. The metabolites most frequently detected in the human brain include 
choline, creatine, glutamate, glutamine, lactate, myo-inositol (mI), and N-acetyl aspartate 
(NAA), but there are at least 25 other less common metabolites that can be assessed by 
MRS.40 Proton (1H) MRS offers better sensitivity compared to other nuclei (phosphorus or 
carbon) and is more likely to detect minor changes in metabolites.40  
 
In vitro nuclear magnetic resonance (NMR) spectroscopy, a correlate of in vivo MRS, can 
identify cultured neurons, glial and meningeal cells by their metabolic properties.41 Cultured 
neural stem cells exhibit high levels of choline and mI, and low concentrations of creatine, a 
profile different from embryonic stem cells or mature cells of the central nervous system.42 A 
spectroscopic peak at 1.28 parts per million (ppm), found in cultured cells and the rat and 
human hippocampi, has been reported as being unique to neural progenitor cells, although 
this specificity has subsequently been questioned.43-47  
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A variety of metabolites in the peri-lesion area can inform on cellular repair mechanisms. 
Both single- and multiple-voxel MRS techniques have been used to non-invasively measure 
in vivo alterations of metabolite profile during stroke recovery in both human studies and in 
animal models. 1H/13C MRS showed significant decrease in NAA, choline, and 
glutamate/glutamine turnover with increased glutamine and lactate at 24 hours in the 
perilesional areas of the rat brain, followed by normalization of NAA, choline, glutamine, 
and glutamate/glutamine turnover at 3 weeks, paralleling neurological improvement.48 These 
alterations in the metabolite profile indicate substantial recovery of the initially impaired 
neural and glial functioning in the lesion border zone over time.48 In humans, acute stroke is 
associated with elevated lactate and reduced NAA in the infarct zone, whereas the peri-infarct 
regions are characterised by lactate levels similar to the core but with NAA concentrations 
significantly higher than inside the infarct.49, 50 In a longitudinal multi-voxel MRS study of 51 
stroke patients, NAA concentrations fell both in infarcted and ipsilesional normal tissue over 
the first 2 weeks, and remained lower than baseline at 3 months, indicating neuronal loss.51 A 
biphasic lactate peak was thought to represent initial tissue hypoxia followed by infiltration 
by inflammatory cells with a high rate of anaerobic glycolysis.51 In another study, higher mI 
concentrations in the spared ipsi- and contra-lesional primary motor cortices of chronic stroke 
patients were thought to reflect astrocyte mediated post-stroke plasticity rather than gliosis.52  
 
MRI contrast labelling offers an alternative approach for in vivo imaging of cellular elements 
during recovery.5, 53, 54Animal studies have employed superparamagnetic (iron oxide-based) 
particles and paramagnetic (gadolinium or manganese-based) agents, some of which are 
approved for human use.5 Paramagnetic agents generate a hyperintense signal on T1-weighted 
MRI, whereas cells harbouring even a single micron-sized iron oxide particle can be seen as 
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hypointense spots on T2 and T2*-weighted MRI, enabling precise anatomical localization and 
tracking of cell migration.55 Neural stem cells labelled in vitro have successfully been 
detected in vivo in animal stroke models by means of MRI following transplantation (Figure 
1).5, 56, 57 A patient receiving an intravenous injection of iron-oxide microbead-labeled bone 
marrow stem cells 2 weeks after an ischemic stroke developed hypointensity compatible with 
iron (stem cell) deposition in the infarct, as detected with T2* MRI 4 days after the 
injection.58 Animal studies also indicate that endogenous neuronal stem/progenitor cells can 
also be labelled using cerebroventricular injections of MRI contrast agents, but their 
application in humans may be limited.55 Labelling can alter cellular functional characteristics, 
and may not allow reliable differentiation between viable and dead cells; and uptake of 
contrast by other cell types such as phagocytes cannot be excluded.5, 53, 57, 59 
 
MRI approaches to detect cellular changes during stroke recovery include the identification 
of progenitor cells by their unique metabolic profile or by labeling with contrast agents. (1H) 
MRS is available as an option on many commercial (human) MRI scanners, although more 
interactive optimisation is often required than is usual for MRI scanning, and considerable 
local expertise is necessary to ensure high quality data. MRS has low sensitivity, which is a 
major limitation if there are very few cells to detect, as is the case in the peri-lesion area 
harbouring sparsely seeded neural progenitors. The low sensitivity also means that large 
imaging voxels are required, which leads to partial volume effects and makes longitudinal 
follow-up harder as the relative concentrations of different components within a voxel may 
change over time. Furthermore, there is no one to one mapping of metabolites to cell types, 
which affects specificity.  
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Axonal remodeling and cortical changes 
Diffusion tensor imaging (DTI) delineates  anatomical connectivity of white matter pathways 
and can detect tract disruption.60 DTI provides two scalar measures, the apparent diffusion 
coefficient (ADC) and fractional anisotropy (FA), which characterize the magnitude of water 
diffusion and the degree of anisotropy for each voxel (Figure 3).24 In addition, careful 
interpretation of axial (parallel to the long axis of the fiber) and radial (perpendicular) 
diffusivity provides measures of axonal and myelination status, respectively.24, 61  
 
Experimental stroke in rats has been characterized by decreased FA in perilesional areas at 3 
days, followed by return to control values after 9 weeks.62 In rat models of stroke, treatment 
with neural progenitor cells, sildenafil or erythropoietin has been associated with increased 
elevation of FA in peri-infarct areas at 5-7 weeks, which has correlated with reorganization of 
axons and myelin on histology, and with improved functional outcome.30, 63, 64 In humans, a 
decrease in FA of the ipsilesional corticospinal tract has been detected during the first 3 
months following ischemic stroke.65 Early fiber tract degeneration has paralleled impaired 
recovery,66 and predicted long-term deficits.65 During a period of up to a few years after 
stroke, human studies (including some using specific interventions such as intonation-based 
speech therapy or brain-computer interface training)67, 68 have observed increasing FA, 
connectivity and fiber number in lesioned and non-lesioned white matter, correlating with 
better functional outcome.67-71 DTI evaluation of motor tract integrity in chronic stroke 
patients can predict motor function and behavioural gains from robotic therapy, motor 
practice, transcranial direct current or epidural motor cortex stimulation.72-77  
 
DTI methods incorporating a single tensor fit to the diffusion at each voxel show an 
anomalous overall lowering of FA where white matter fiber tracts cross, despite the presence 
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of highly oriented tissue.24 Newer q-space based and High Angular Resolution Diffusion 
Imaging (HARDI) techniques (e.g. diffusion spectrum imaging (DSI), q-ball, and persistent 
angular structure MRI (PAS-MRI)) provide model-independent analysis to obtain multiple 
tensors per voxel and thereby extract information on complex tissue structure including 
crossing fiber tracts.60, 78-80 These techniques are particularly relevant in detecting randomly 
oriented crossing axons during early-stage axonal remodeling in stroke recovery.60 In 
addition, changes in axonal density associated with stroke recovery can be measured using 
MRI diffusion entropy, a technique not dependent on axonal orientation.60  
 
Manganese-enhanced MRI (MEMRI) is a novel tool for in vivo assessment of neuronal 
networks.81 MEMRI is based on the detection of manganese (Mn2+), which enters active 
neurons and is transported axonally and trans-synaptically.81 Paramagnetic manganese 
shortens the T1 relaxation time and increases signal intensity on T1-weighted MRI. In a rat 
stroke model, decreased manganese enhancement in the ipsilateral sensorimotor network at 2 
weeks after stroke was followed by enhanced connectivity on MEMRI and histology at 10 
weeks, which correlated with behavioural recovery.82  
 
MRI also allows the measurement of cortical thickness and gray matter density or volume.83, 
84 In chronic stroke patients, atrophy of gray matter in remote brain regions (likely a 
consequence of impaired connectivity) predicted a lesser extent of motor improvement from 
subsequent constraint-induced movement therapy or epidural motor cortex stimulation.72, 85 
Increases in gray matter have been demonstrated in compensatory brain regions of chronic 
stroke patients,86 and following constraint-induced movement therapy in parallel with 
functional improvements.87 The mechanism of this increase in gray matter is likely to be 
multifactorial involving both neural and non-neural elements.86  
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In summary, DTI and MEMRI are potent in vivo techniques to study white matter structure, 
and MRI also provides tools to measure dimensions of gray matter. DTI is available either as 
standard or as an option on most commercial MRI scanners, which also routinely provide 
volumetric T1-weighted measurements. However there are potential limitations. The 
interpretation of tractography data requires experience and knowledge of white matter 
anatomy. Complex analytic methods are computationally demanding, and require longer 
processing times.88 Several tractography algorithms have been described, but there is no 
consensus on the best method to use. Only few studies have validated tractography with 
dissection or histology, and knowledge on the relationship of MR measures and specific 
axonal events is limited. DTI cannot differentiate anterograde from retrograde connections or 
determine whether a pathway is functional.88 Manganese is neurotoxic at high concentrations 
or after chronic exposure, which limits MEMRI-based neuronal tracing in human studies.89  
 
 
General considerations for human application and future directions 
Non-invasive MRI biomarkers may provide deeper insights into specific neural events 
underlying stroke recovery. Furthermore, they may prove helpful to estimate prognosis, and 
identify patients who may benefit from specific interventions.90, 91 The use of MRI 
biomarkers as surrogate end points may facilitate the screening of novel therapeutic 
interventions prior to large clinical trials. Considerations for surrogate markers should include 
feasibility of translation from animal to human studies, causal role in the disease process, and 
capacity to capture the net effect of therapy on clinical outcome. 91 MRI may not be the best 
brain-mapping tool for every aspect of stroke recovery: PET has a higher potential to 
characterize regional brain metabolism, and receptor and transporter distribution and 
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density;6 transcranial magnetic stimulation (TMS) has advantages in evaluating the 
physiological properties of neural populations;92 whereas magnetoencephalograpy (MEG) 
offers superior temporal resolution.93  
 
The use of MRI to monitor recovery in humans presents additional challenges. There are 
well-known contraindications to MRI, and the administration of contrast agents may cause 
complications, particularly if given on multiple occasions.94, 95 The most feasible clinical 
research protocols for the study of large patient populations in a longitudinal fashion would 
employ non-contrast techniques that are available on current scanner platforms (Table 1), 
with keeping in mind that sessions longer than 60 minutes are unlikely to be easily tolerated 
by most stroke patients. Imaging biomarkers are time dependent: some may be most useful to 
monitor recovery early after stroke (e.g. CBF),25 whereas others may have limited value in 
the very early phase (e.g. FA may be transiently elevated on DTI as a consequence of 
edema).96 The selection of regions of interest (ROI) for quantitative MRS, perfusion, or 
diffusion measurements requires hypotheses about the areas likely to be involved in post-
stroke recovery, and focal abnormalities are often much easier to interpret if data from 
presumed normal tissue in the contralesional hemisphere are available for comparison.40 It is 
also advisable that studies for research purposes use age-, gender-, and anatomically matched 
data from control subjects for comparison.40  
 
Developments in MRI technology such as higher field strengths and faster MR acquisition 
methods will shorten scan times and make complex measurements more feasible. Further 
advantages of high field include improved spectral resolution, allowing the detection of more 
compounds with MRS,40 and direct visualization of brain structures such as specific major 
fibre bundles.97 However, high-field MRI is also associated with more prominent artefacts.98 
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Molecular imaging is another promising approach which may in future become more readily 
available. This may allow the monitoring of angiogenesis using paramagnetic contrast agents 
targeted against endothelial integrin αvβ3.99, 100 Molecular MRI techniques for tracking 
cellular elements include imaging reporter genes (either with or without exogenous contrast 
administration) or contrast agent linked to receptor-specific antibodies.5, 53 Contrast materials 
based on a heteronuclear (e.g. 19F or 13C) approach, or ‘responsive’ agents that change 
contrast due to their altered magnetic properties (e.g. relaxation or chemical shift) in response 
to dynamic changes in physiological, enzymatic and other metabolic properties are other 
potential advances.53  
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Figure legend 
 
 
Figure 1. Imaging of transplanted and endogenous neural stem cells (NSCs) 
A. Mouse neural stem cells labeled with a bimodal gadolinium-rhodamine (GRID) contrast 
agent can be detected both by MRI and fluorescence histology. The overlay of both images 
confirms good correspondence between the areas of transplanted cells on both imaging 
modalities. The blue arrows indicate the area of CA1 with transplanted cells, whereas the 
yellow arrows point to the injection tract.  
B. In rats with global ischaemic damage (15 minutes of 4 vessel-occlusion), transplanted 
NSCs (in red due to rhodamine chelate from contrast agent) migrate into the CA1 cell layer 
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of the damaged hippocampus (NeuN+ neurons marked in green), corresponding to the 
hippocampal region on the MR image (blue arrows). Detection of endogenous neurogenesis, 
however, constitutes a major challenge as only a small proportion of cells within the dentate 
gyrus (white arrows) are proliferating neural stem cells or newly generated neurons.  
C. A similar challenge lies in the in vivo detection of neurogenesis in the sub-ependymal 
zone (SEZ, white arrows) next to the lateral ventricle. The SEZ is a very dense cellular region 
as can be seen here with DAPI (blue) labeling of every cell nucleus, delineating a thin line 
along the lateral ventricle. Although this zone is normally only a few cells deep, some parts 
of SEZ expand due to a stroke (area delineated with orange line), still remaining within 
approximately 100 μm in thickness. In vivo ventricular motion as well as the dramatic 
variation in tissue type will be major challenges in the detection metabolic changes within 
this specific region. However, cells migrating into the peri-infarct area (astrocytes stained 
with GFAP are visible here in green) potentially can affect the metabolite profile of this area, 
although again the numbers infiltrating this area are relatively small compared to the overall 
volume of the peri-infarct area. Neuronal cells (NeuN in red) are dramatically decreased even 
in the peri-infract area, and very little cell replacement occurs due to endogenous 
neurogenesis. 
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Figure 2. Group-average CBF maps using ASL in 6 patients with a cortical ischaemic stroke 
in the left middle cerebral artery territory. At 3 weeks after stroke (A) hypoperfusion in the 
affected hemisphere (arrows) and crossed-cerebellar diaschisis (arrowheads) is demonstrated. 
At 15 weeks perfusion (B, displayed with the same threshold as in A) is restored in the 
contralesional cerebellum (arrowheads), and is increased in the contralesional hemisphere 
(arrows). 
 
STROKE/2011/649244 R2 
 
Figure 3. FA maps are easily obtainable on current scanners. FA values are decreased in the 
ipsilesional internal capsule (arrow) in a patient with left hemispheric ischaemic stroke.  
 
STROKE/2011/649244 R2 
Table 1. MR options for imaging post-stroke recovery  
Technique Need for 
exogenous 
contrast 
agent 
Parameter measured Availability 
on current 
scanner 
platform 
Angiogenesis    
DSC-MRI Yes CBF, CBV Yes 
ASL No CBF Yes 
SSCE-MRI Yes Average vessel size, MVD No 
DCE-MRI Yes Ki No 
Gradient/spin echo BOLD No Deoxygenated haemoglobin Yes 
SWI No Deoxygenated haemoglobin Yes 
    
Cells    
MRS No Concentrations of metabolites Yes 
Cell labeling Yes Properties of contrast in cells No 
    
Axonal remodeling    
DTI No ADC, FA, Q-space based and 
HARDI measurements 
Yes 
MEMRI Yes Paramagnetic manganese in 
neural networks 
No 
    
Brain volume    
T1-weighted volumetry No Regional gray matter volume Yes 
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ADC, apparent diffusion coefficient; ASL, arterial spin labelling; BOLD, blood oxygenation 
level-dependent imaging; CBF, cerebral blood flow; CBV, cerebral blood volume; DCE-
MRI, dynamic contrast-enhanced MRI; DSC-MRI, dynamic susceptibility contrast-enhanced 
MRI; DTI, diffusion tensor imaging; FA, fractional anisotropy; HARDI, High Angular 
Resolution Diffusion Imaging; Ki, blood brain barrier transfer constant; MEMRI, manganese-
enhanced MRI; MRS, magnetic resonance spectroscopy; MVD, microvascular density; 
SSCE-MRI, steady state susceptibility contrast-enhanced MRI; SWI, susceptibility weighted 
imaging.  
